Arkolith/Insider Trading/NTLA/Form 4

Dulac Edward J III

EVP, Chief Financial OfficerIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Jul 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$105K
Net Open-Market Flow
-$105K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 23, 2025Sell(S)7K$14.02$105K106K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-098774) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML